NFATC1 and rheumatoid arthritis: Taken together, these data indicated that HAR might play an inhibitory action on RA via multiple targets, and further studies are needed to clarify its direct mechanism and binding sites, by the action of c-Fos and NFATc1 inhibitors and comparison of the effect of HAR and positive control such as denosumab.